{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:27Z","timestamp":1788871887266,"version":"build-2803163510"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Vestre Viken Hospital Trust (Partial Support)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>\n                      Infections caused by cytomegalovirus (CMV), parvovirus B19 (B19), and rubella can lead to serious complications in pregnant women. The aim of this study was to determine the susceptibility to CMV, B19, and rubella antibodies in pregnant women in Norway. Consecutive sera samples were collected from pregnant women in two different regions in Norway. Sera were collected from age groups; \u226419, 20\u201324, 25\u201329, 30\u201334, 35\u201339, and \u226540 years old. Of the 2,000 pregnant women tested, anti\u2010CMV IgG was positive in 62.8% anti\u2010parvovirus B19 IgG in 59.7% and anti\u2010rubella IgG in 94.4%. CMV IgG susceptibility has decreased in pregnant women less than 30 years of age, from 60% in a study conducted in 1973\u20131974 to 37.2% in present study. There was a significant difference in CMV IgG seropositivity rate between the two regions (58.6% and 67.1%). Serum levels of rubella IgG was lowest in age group 25\u201329 years with a positivity rate of 91.0%. Women born before vaccination with two doses of MMR started, had both a higher positivity rate and significantly higher levels of rubella antibody titre, 96.1% and 82.2\u2009IU\/ml compared to those born after 92.9% and 41.7\u2009IU\/ml. Significantly lower anti\u2010rubella IgG titre found in the youngest age groups highlights the need for continued antenatal screening. A considerable increase in anti\u2010CMV\u2010IgG seropositivity rate was observed and might be associated with higher rate of breastfeeding and a higher percentage attending day\u2010care centres.\n                      <jats:bold>\n                        <jats:italic>J. Med. Virol. 86:820\u2013826, 2014<\/jats:italic>\n                        .\n                      <\/jats:bold>\n                      \u00a9 2013 Wiley Periodicals, Inc.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jmv.23757","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T21:48:17Z","timestamp":1381528097000},"page":"820-826","source":"Crossref","is-referenced-by-count":31,"title":["Susceptibility to cytomegalovirus, parvovirus B19 and age\u2010dependent differences in levels of rubella antibodies among pregnant women"],"prefix":"10.1002","volume":"86","author":[{"given":"Regine","family":"Barlinn","sequence":"first","affiliation":[{"name":"Department of Virology Norwegian Institute of Public Health Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsti","family":"Vainio","sequence":"additional","affiliation":[{"name":"Department of Virology Norwegian Institute of Public Health Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helvi Holm","family":"Samdal","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology Drammen Hospital, Vestre Viken Hospital Trust Drammen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein Arne","family":"Nordb\u00f8","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology St. Olavs Hospital Trondheim University Hospital Trondheim Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"N\u00f8kleby","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control Norwegian Institute of Public Health Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne G.","family":"Dudman","sequence":"additional","affiliation":[{"name":"Department of Virology Norwegian Institute of Public Health Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.045"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.695"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/21.4.439"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/528993"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.544"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.940"},{"key":"e_1_2_6_8_1","unstructured":"Folkehelseinstituttet.2012.\u00c5rstabeller for medisinsk f\u00f8dselsregister 2010. F\u00f8dsler i Norge.www.fhi.no: Folkehelseinstituttet Division of epidemiology. Report nr ISSN electronic version 1504\u20133320."},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980010001771"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2807\/esm.08.06.00415-en","article-title":"WHO European Region's strategy for elimination of measles and congenital rubella infection","volume":"8","author":"Hanon FX","year":"2003","journal-title":"Euro Surveillance"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016348409156698"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.659"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/IDOG\/2006\/80383"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.535"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0021932000017247"},{"key":"e_1_2_6_16_1","first-page":"26","article-title":"Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe","volume":"14","author":"Ludwig A","year":"2009","journal-title":"Euro Surveillance"},{"key":"e_1_2_6_17_1","unstructured":"M\u00e5nedsmeldingene.National laboratory surveillance system in Norway. (Accessed 14 February 2013).http:\/\/lab.fhi.no."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.08.037"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268807009661"},{"key":"e_1_2_6_20_1","unstructured":"MSIS.Norwegian Surveillance System for Communicable Diseases(MSIS). (Accessed 14 February 2013) Available from:www.msis.no."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-6400-8.00028-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.484"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/106.2.170"},{"key":"e_1_2_6_24_1","unstructured":"Statistics Norway. (accessed 14 february 2013). Avaiable from:http:\/\/www.ssb.no\/english\/subjects\/04\/02\/10\/barnehager_en\/."},{"key":"e_1_2_6_25_1","volume-title":"Norwegian Institute of Public Health (NIPH). Nasjonalt vaksinasjonsregister (SYSVAK).[National vaccine register\u2010SYSVAK]","author":"SYSVAK"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.12.1099"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2009.09.003"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq085"},{"key":"e_1_2_6_29_1","unstructured":"WHO.World Health Organization (WHO)(Accessed 14 February 2013). Available from:http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/ScheduleResult.cfm."}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.23757","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.23757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:19:46Z","timestamp":1696335586000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.23757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1002\/jmv.23757"],"URL":"https:\/\/doi.org\/10.1002\/jmv.23757","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]}}}